Skye Bioscience Cash from Operations (TTM) Analysis

Skye Bioscience Inc (SKYE)

12.99 +0.21 (+1.64%) USD | NASDAQ | May 02, 12:46

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-13.95M
September 30, 2023	-14.98M
June 30, 2023	-12.98M
March 31, 2023	-13.89M
December 31, 2022	-12.74M
September 30, 2022	-9.841M
June 30, 2022	-9.271M
March 31, 2022	-8.042M
December 31, 2021	-6.475M
September 30, 2021	-6.292M
June 30, 2021	-6.780M
March 31, 2021	-6.136M
December 31, 2020	-6.054M
September 30, 2020	-5.771M
June 30, 2020	-5.286M
March 31, 2020	-5.863M
December 31, 2019	-6.028M
September 30, 2019	-5.539M
June 30, 2019	-4.867M
March 31, 2019	-4.321M
December 31, 2018	-3.943M

Date	Value
September 30, 2018	-5.072M
June 30, 2018	-4.356M
March 31, 2018	-3.568M
December 31, 2017	-3.331M
September 30, 2017	-1.850M
June 30, 2017	-2.262M
March 31, 2017	-3.221M
December 31, 2016	-3.553M
September 30, 2016	-4.004M
June 30, 2016	-4.787M
March 31, 2016	-4.125M
December 31, 2015	-3.728M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
July 31, 2014	-0.0017M
April 30, 2014	-0.0014M
January 31, 2014	-0.0062M
October 31, 2013	-0.0145M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-14.98M

Minimum

Sep 2023

-4.867M

Maximum

Jun 2019

-8.463M

Average

-6.475M

Median

Dec 2021

Cash from Operations (TTM) Benchmarks